Blood transfusion and EPO were administered to 23 (15%) and twelve (8%) patients with normal ITPase; and to 4 (7%) and none (0%) of the patients with ITPase deficiency (p = 0.089 and p = 0.024, respectively). The gene discussed is ITPA; the disease is hyperinsulinemic hypoglycemia, familial, 4.